Hans Sievertsson
Vorsitzender bei MIP Technologies AB
Profil
Hans Sievertsson is currently the Chairman at Clinitrac AB, MIP Technologies AB, and Director at Catella Healthcare AB.
He previously held positions as Director at Creative Antibiotics AB, Vice President at Bofors Defence AB and KABI-AM, Head-Research & Development at Pharmacia AB, and Professor at the University of Uppsala.
He completed his undergraduate degree at the University of Uppsala.
Aktive Positionen von Hans Sievertsson
| Unternehmen | Position | Beginn |
|---|---|---|
MIP Technologies AB
 MIP Technologies AB Miscellaneous Commercial ServicesCommercial Services MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides. | Vorsitzender | - |
Clinitrac AB
 Clinitrac AB Packaged SoftwareTechnology Services Clinitrac AB develops wireless patient diaries. The firm offers solutions for pharmaceutical, biotechnology, and medical device companies. The company was founded in 1995 and is located in Stockholm, Sweden. | Vorsitzender | - |
Catella Healthcare AB
 Catella Healthcare AB Investment ManagersFinance Part of Catella AB, Catella Healthcare AB is an alternative investment manager. The company is based in Stockholm, Sweden. | Direktor/Vorstandsmitglied | 23.09.2009 |
Ehemalige bekannte Positionen von Hans Sievertsson
| Unternehmen | Position | Ende |
|---|---|---|
| CREATIVE ANTIBIOTICS SWEDEN AB | Direktor/Vorstandsmitglied | - |
| University of Uppsala | Corporate Officer/Principal | - |
Bofors Defence AB
 Bofors Defence AB Aerospace & DefenseElectronic Technology Part of BAE Systems Plc, Bofors Defence AB is a Swedish company that manufactures ammunition for weapons. The company is based in Karlskoga, Sweden. | Corporate Officer/Principal | - |
| Pharmacia AB | Corporate Officer/Principal | - |
| KABI-AM | Corporate Officer/Principal | - |
Ausbildung von Hans Sievertsson
| University of Uppsala | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Creative Antibiotics AB
 Creative Antibiotics AB Pharmaceuticals: MajorHealth Technology Creative Antibiotics AB engages in the manufacture of pharmaceuticals products. The company was founded in 2000 and is headquartered in Umeå, Sweden. | Health Technology |
Bofors Defence AB
Bofors Defence AB Aerospace & DefenseElectronic Technology Part of BAE Systems Plc, Bofors Defence AB is a Swedish company that manufactures ammunition for weapons. The company is based in Karlskoga, Sweden. | Electronic Technology |
| Pharmacia AB | Health Technology |
| KABI-AM | Consumer Services |
Clinitrac AB
Clinitrac AB Packaged SoftwareTechnology Services Clinitrac AB develops wireless patient diaries. The firm offers solutions for pharmaceutical, biotechnology, and medical device companies. The company was founded in 1995 and is located in Stockholm, Sweden. | Technology Services |
Catella Healthcare AB
Catella Healthcare AB Investment ManagersFinance Part of Catella AB, Catella Healthcare AB is an alternative investment manager. The company is based in Stockholm, Sweden. | Finance |
MIP Technologies AB
MIP Technologies AB Miscellaneous Commercial ServicesCommercial Services MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides. | Commercial Services |
